8-K
filed July 13, 2022, 7:59 PM ET
ticker SONM
CIK 0001178697
other material
confidence high
sentiment positive
materiality 0.85
Sonim completes $12.5M first closing of equity investment from AJP; control changes hands
DNA X, Inc.
- First closing of $12.5M equity investment by AJP Holding at $0.84/share; AJP now owns ~40.7% of Sonim.
- Second closing for $5M expected ~Aug 1; combined AJP and CEO Peter Liu will own ~52%.
- Board reconstituted: new directors Wang, Steenstra, Cassano; Kneuer and Swenson resigned.
- CFO Robert Tirva resigned; Clay Crolius appointed CFO with base salary $275K.
- Press release: $15.9M in carrier orders; expansion into semi-rugged and 5G markets.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Robert Tirva resigned as President, Chief Financial Officer and Chief Operating Officer at DNA X, Inc..
- Action
- resigned
- Role
- President, Chief Financial Officer and Chief Operating Officer
Exact text from the filing
On July 13, 2022, Robert Tirva, President, Chief Financial Officer and Chief Operating Officer (principal financial and accounting officer) of the Company resigned from his positions with the Company and its affiliates.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Clay Crolius was appointed as Chief Financial Officer at DNA X, Inc..
- Action
- appointed
- Role
- Chief Financial Officer
Exact text from the filing
the Board appointed Clay Crolius as Chief Financial Officer (principal financial and accounting officer) of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
John Kneuer resigned as Director at DNA X, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
John Kneuer and Sue Swenson resigned from the Board and each respective committee of the Board to which they were appointed.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jeffrey Wang was appointed as Director, Chairman of the Board at DNA X, Inc..
- Action
- appointed
- Role
- Director, Chairman of the Board
Exact text from the filing
Jeffrey Wang, Director, Chairman of the Board
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Sue Swenson resigned as Director at DNA X, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
John Kneuer and Sue Swenson resigned from the Board and each respective committee of the Board to which they were appointed.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.